Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization

Table 1 Demographics of participants, n (%)

Parameters	Good prognosis group (n = 88)	Poor prognosis group (n = 74)	t/χ2	P value
Sex (male)	72 (81.82)	58 (78.38)	0.300	0.584
Age (years)	61.64 ± 8.25	61.78 ± 9.99	0.103	0.918
Body mass index (kg/m²)	24.46 ± 2.40	24.44 ± 2.41	0.036	0.971
Diabetes	13 (14.77)	10 (13.51)	0.052	0.819
Hypertension	23 (26.14)	20 (27.03)	0.016	0.898
Smoking history	24 (27.27)	25 (33.78)	0.808	0.369
Drinking history	26 (29.55)	22 (29.73)	0.001	0.980
Family history of liver cancer	14 (15.91)	9 (12.16)	0.463	0.496
Hepatitis B	67 (76.14)	49 (66.22)	1.946	0.163
Hepatitis C	8 (9.09)	18 (24.32)	6.923	0.009
Cirrhosis	66 (75)	48 (64.86)	1.980	0.159